Lombard Odier Asset Management Europe Ltd Makes New Investment in Agilent Technologies, Inc. $A

Lombard Odier Asset Management Europe Ltd bought a new position in Agilent Technologies, Inc. (NYSE:AFree Report) during the second quarter, Holdings Channel.com reports. The firm bought 38,707 shares of the medical research company’s stock, valued at approximately $5,141,000.

Several other institutional investors also recently modified their holdings of A. Brighton Jones LLC increased its position in shares of Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. Jones Financial Companies Lllp boosted its stake in Agilent Technologies by 15.9% in the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after acquiring an additional 769 shares during the last quarter. Geneos Wealth Management Inc. grew its position in shares of Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after acquiring an additional 212 shares during the period. Acadian Asset Management LLC increased its stake in shares of Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after purchasing an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $273,000.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

  • Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
  • Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
  • Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
  • Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Agilent Technologies Stock Performance

Shares of A opened at $154.47 on Friday. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $163.75. The stock’s 50-day simple moving average is $140.30 and its 200 day simple moving average is $127.04. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.62 and a current ratio of 2.05. The stock has a market capitalization of $43.63 billion, a price-to-earnings ratio of 30.41, a price-to-earnings-growth ratio of 2.72 and a beta of 1.25.

Agilent Technologies (NYSE:AGet Free Report) last posted its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same quarter in the previous year, the firm earned $1.37 EPS. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A has been the subject of several research reports. Sanford C. Bernstein increased their price objective on Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a report on Thursday. The Goldman Sachs Group boosted their price objective on Agilent Technologies from $155.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday. Morgan Stanley upped their price objective on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Barclays lifted their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, Stifel Nicolaus upped their price target on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $170.33.

Read Our Latest Stock Report on Agilent Technologies

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

See Also

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.